Thermo Fisher announced that it has completed its acquisition of The Binding Site Group, a global leader in specialty diagnostics, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash transaction valued at GBP 2.3B, or $2.8B at current exchange rates. Thermo Fisher announced the agreement to acquire The Binding Site on October 31, 2022. The transaction is expected to be accretive to adjusted earnings per share by 7c in 2023.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TMO:
- Thermo Fisher’s monkeypox test granted emergency use authorization by FDA
- Thermo Fisher initiated with a Buy at Deutsche Bank
- Thermo Fisher Stock (NYSE:TMO): Is Its Superb Quality Worth the Price?
- Tecogen appoints Albertine to board of directors
- Thermo Fisher initiated with an Outperform at RBC Capital
